Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
ChromaDex Co. stock logo
CDXC
ChromaDex
$3.52
-8.1%
$3.25
$1.25
$4.65
$265.84M1.96253,806 shs315,059 shs
RiverNorth Opportunities Fund, Inc. stock logo
RIV
RiverNorth Opportunities Fund
$12.17
+0.2%
$11.84
$9.63
$12.43
N/AN/A80,277 shs51,193 shs
Tilray Inc stock logo
TLRY
Tilray
$1.98
+1.5%
$2.00
$1.50
$3.40
$1.53B2.3630.86 million shs20.63 million shs
7 Energy Stocks to Buy and Hold Forever Cover

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
ChromaDex Co. stock logo
CDXC
ChromaDex
-8.09%-6.38%-11.56%+130.07%+139.46%
RiverNorth Opportunities Fund, Inc. stock logo
RIV
RiverNorth Opportunities Fund
+0.25%+1.93%+1.33%+3.05%+9.15%
Tilray Inc stock logo
TLRY
Tilray
+1.54%-1.98%-3.65%+5.32%-28.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
ChromaDex Co. stock logo
CDXC
ChromaDex
3.6884 of 5 stars
3.52.00.04.11.90.80.6
RiverNorth Opportunities Fund, Inc. stock logo
RIV
RiverNorth Opportunities Fund
N/AN/AN/AN/AN/AN/AN/AN/A
Tilray Inc stock logo
TLRY
Tilray
1.0585 of 5 stars
3.11.00.00.01.90.01.3

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
ChromaDex Co. stock logo
CDXC
ChromaDex
3.00
Buy$6.2076.14% Upside
RiverNorth Opportunities Fund, Inc. stock logo
RIV
RiverNorth Opportunities Fund
N/AN/AN/AN/A
Tilray Inc stock logo
TLRY
Tilray
2.25
Hold$2.7136.78% Upside

Current Analyst Ratings

Latest TLRY, RIV, and CDXC Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/9/2024
ChromaDex Co. stock logo
CDXC
ChromaDex
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$6.00
4/10/2024
Tilray Inc stock logo
TLRY
Tilray
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy$4.25 ➝ $4.00
4/10/2024
Tilray Inc stock logo
TLRY
Tilray
CIBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$2.25 ➝ $2.00
4/9/2024
ChromaDex Co. stock logo
CDXC
ChromaDex
Roth Mkm
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$4.25 ➝ $6.00
4/5/2024
Tilray Inc stock logo
TLRY
Tilray
Alliance Global Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral$2.25 ➝ $2.75
(Data available from 5/10/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
ChromaDex Co. stock logo
CDXC
ChromaDex
$83.57M3.18N/AN/A$0.38 per share9.26
RiverNorth Opportunities Fund, Inc. stock logo
RIV
RiverNorth Opportunities Fund
$33.73MN/AN/AN/AN/AN/A
Tilray Inc stock logo
TLRY
Tilray
$210.48M7.28N/AN/A$5.07 per share0.39

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
ChromaDex Co. stock logo
CDXC
ChromaDex
-$4.94M-$0.07N/A58.67N/A-5.91%-17.81%-9.17%8/14/2024 (Estimated)
RiverNorth Opportunities Fund, Inc. stock logo
RIV
RiverNorth Opportunities Fund
N/AN/A0.00N/AN/AN/AN/AN/A
Tilray Inc stock logo
TLRY
Tilray
-$1.45B-$0.44N/AN/AN/A-43.98%-2.68%-2.09%7/24/2024 (Estimated)

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
ChromaDex Co. stock logo
CDXC
ChromaDex
N/AN/AN/AN/AN/A
RiverNorth Opportunities Fund, Inc. stock logo
RIV
RiverNorth Opportunities Fund
$1.5312.57%+19.44%N/A1 Years
Tilray Inc stock logo
TLRY
Tilray
N/AN/AN/AN/AN/A

Latest TLRY, RIV, and CDXC Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/4/2024
RiverNorth Opportunities Fund, Inc. stock logo
RIV
RiverNorth Opportunities Fund
monthly$0.128912.9%6/14/20246/14/20246/28/2024
4/3/2024
RiverNorth Opportunities Fund, Inc. stock logo
RIV
RiverNorth Opportunities Fund
monthly$0.128912.9%5/14/20245/15/20245/31/2024
4/1/2024
RiverNorth Opportunities Fund, Inc. stock logo
RIV
RiverNorth Opportunities Fund
Monthly$0.128912.89%5/14/20245/15/20245/31/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
ChromaDex Co. stock logo
CDXC
ChromaDex
N/A
2.40
1.70
RiverNorth Opportunities Fund, Inc. stock logo
RIV
RiverNorth Opportunities Fund
N/AN/AN/A
Tilray Inc stock logo
TLRY
Tilray
0.11
1.92
1.18

Ownership

Institutional Ownership

CompanyInstitutional Ownership
ChromaDex Co. stock logo
CDXC
ChromaDex
15.41%
RiverNorth Opportunities Fund, Inc. stock logo
RIV
RiverNorth Opportunities Fund
N/A
Tilray Inc stock logo
TLRY
Tilray
9.35%

Insider Ownership

CompanyInsider Ownership
ChromaDex Co. stock logo
CDXC
ChromaDex
10.57%
RiverNorth Opportunities Fund, Inc. stock logo
RIV
RiverNorth Opportunities Fund
N/A
Tilray Inc stock logo
TLRY
Tilray
0.68%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
ChromaDex Co. stock logo
CDXC
ChromaDex
10675.52 million67.54 millionOptionable
RiverNorth Opportunities Fund, Inc. stock logo
RIV
RiverNorth Opportunities Fund
N/AN/AN/ANot Optionable
Tilray Inc stock logo
TLRY
Tilray
1,600774.03 million768.77 millionOptionable

TLRY, RIV, and CDXC Headlines

SourceHeadline
Tilray (NASDAQ:TLRY) Trading 0.5% Higher Tilray (NASDAQ:TLRY) Trading 0.5% Higher
marketbeat.com - May 9 at 7:55 PM
7 Cannabis Stocks to Buy for a Smoking-Hot 20247 Cannabis Stocks to Buy for a Smoking-Hot 2024
investorplace.com - May 9 at 9:19 AM
Tilray (NASDAQ:TLRY)  Shares Down 2% Tilray (NASDAQ:TLRY) Shares Down 2%
marketbeat.com - May 8 at 5:53 PM
Tilray (NASDAQ:TLRY) Shares Up 0.5%Tilray (NASDAQ:TLRY) Shares Up 0.5%
marketbeat.com - May 7 at 5:14 PM
Cashing In on Cannabis: 3 Stocks Primed to Surge on Federal ReformsCashing In on Cannabis: 3 Stocks Primed to Surge on Federal Reforms
investorplace.com - May 7 at 7:00 AM
Tilray (NASDAQ:TLRY) Stock Price Up 2.9%Tilray (NASDAQ:TLRY) Stock Price Up 2.9%
marketbeat.com - May 6 at 8:24 PM
Tilray (NASDAQ:TLRY) Shares Up 6.9%Tilray (NASDAQ:TLRY) Shares Up 6.9%
americanbankingnews.com - May 5 at 5:18 AM
Tilray (NASDAQ:TLRY) Stock Price Up 6.9%Tilray (NASDAQ:TLRY) Stock Price Up 6.9%
marketbeat.com - May 3 at 10:50 PM
Tilray (TSE:TLRY) Recovers after Revealing New Mexican-Style BrewTilray (TSE:TLRY) Recovers after Revealing New Mexican-Style Brew
msn.com - May 3 at 10:47 PM
10 Barrel Brewing Introduces Pub Cerveza: a New Twist on ‘Cheap Fun.’ Series10 Barrel Brewing Introduces Pub Cerveza: a New Twist on ‘Cheap Fun.’ Series
finance.yahoo.com - May 3 at 10:47 PM
10 Barrel Brewing Introduces Pub Cerveza: a New Twist on ‘Cheap Fun. Series10 Barrel Brewing Introduces Pub Cerveza: a New Twist on ‘Cheap Fun.' Series
globenewswire.com - May 3 at 7:07 AM
Cannabis Stocks: Game-Changing Catalyst for the Sector?Cannabis Stocks: Game-Changing Catalyst for the Sector?
marketbeat.com - May 3 at 7:01 AM
Cannabis Stocks: Game-Changing Catalyst for the Sector?Cannabis Stocks: Game-Changing Catalyst for the Sector?
marketbeat.com - May 3 at 7:00 AM
Tilray (NASDAQ:TLRY) Shares Gap Down to $2.47Tilray (NASDAQ:TLRY) Shares Gap Down to $2.47
americanbankingnews.com - May 3 at 6:14 AM
Tilray Brands Launches XMG Zero, a New ‘Better for You Cannabis BeverageTilray Brands Launches XMG Zero, a New ‘Better for You' Cannabis Beverage
globenewswire.com - May 2 at 7:00 AM
Why Canopy Growth, Tilray, and Cronos Group Stocks Just CrateredWhy Canopy Growth, Tilray, and Cronos Group Stocks Just Cratered
fool.com - May 1 at 3:13 PM
Tilray (NASDAQ:TLRY)  Shares Down 17.4% Tilray (NASDAQ:TLRY) Shares Down 17.4%
marketbeat.com - May 1 at 2:29 PM
3 Meme Stocks to Buy on the Dip: April 20243 Meme Stocks to Buy on the Dip: April 2024
investorplace.com - May 1 at 2:13 PM
Cannabis Stocks CGC, ACB, TLRY Drop After Huge Rescheduling RallyCannabis Stocks CGC, ACB, TLRY Drop After Huge Rescheduling Rally
investorplace.com - May 1 at 12:11 PM
The next pot of gold? Marijuana stocks surge higher on promise of reclassificationThe next pot of gold? Marijuana stocks surge higher on promise of reclassification
finbold.com - May 1 at 7:59 AM
Widmer Brothers Brewing Launches New Hefe Variety Pack With Revamped Versions of the Original American HefeweizenWidmer Brothers Brewing Launches New Hefe Variety Pack With Revamped Versions of the Original American Hefeweizen
globenewswire.com - May 1 at 7:00 AM
Heres the risk for buying TLRY, CGC, MSOS, and SNDL stocksHere's the risk for buying TLRY, CGC, MSOS, and SNDL stocks
invezz.com - May 1 at 6:56 AM
Tilray Brands Stock vs. Bitcoin: Which Investment Is Worth the Risk?Tilray Brands Stock vs. Bitcoin: Which Investment Is Worth the Risk?
fool.com - May 1 at 6:24 AM
Stock Traders Buy High Volume of Call Options on Tilray (NASDAQ:TLRY)Stock Traders Buy High Volume of Call Options on Tilray (NASDAQ:TLRY)
americanbankingnews.com - May 1 at 1:58 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

ChromaDex logo

ChromaDex

NASDAQ:CDXC
ChromaDex Corporation operates as a bioscience company focusing on developing healthy aging products. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingredients directly to consumers and distributors; and develops and commercializes proprietary-based ingredient technologies and supplies these ingredients as raw materials to the manufacturers of consumer products. The company also commercializes NAD+ precursor nicotinamide riboside as the flagship ingredient NIAGEN; NIAGEN as an active ingredient in its consumer products under the TRU NIAGEN name; and Immulina, a spirulina extract with predominant active compounds of Braun-type lipoproteins for supporting human immune function. In addition, it offers phytochemical reference standards, and other research and development services. The company distributes TRU NIAGEN products direct to consumers through its propriety e-commerce platform TRUNIAGEN.com, Amazon, ShopHQ, and other internet marketplaces, as well as specialty retailers and direct healthcare practitioners in the United States. ChromaDex Corporation was founded in 1999 and is headquartered in Los Angeles, California.
RiverNorth Opportunities Fund logo

RiverNorth Opportunities Fund

NYSE:RIV
RiverNorth Opportunities Fund, Inc. is a close ended equity mutual fund co- launched and co- managed by ALPS Advisors, Inc. and RiverNorth Capital Management, LLC. It invests in the equity markets. The fund seeks to invest in stocks of companies operating across the diversified sectors. RiverNorth Opportunities Fund, Inc. was formed on December 24, 2015 and is domiciled in the United States.
Tilray logo

Tilray

NASDAQ:TLRY
Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc. is headquartered in Nanaimo, Canada.